Breast Breaking News

The association between young age atmetastatic breast cancer diagnosis andoverall survival in the EMBRACE study

GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity

Impact of Anthracyclines in Genomic High Risk, Node-Negative, HR-Positive/HER2-Negative Breast Cancer

Iodine Seed−Marking Protocol for Response-Guided Axillary TreatmentAfter Systemic Therapy for Node-Positive Breast Cancer

Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay

Biology is Queen: The Oncotype DX 21‑Gene Recurrence ScoreHas Stronger Prognostic Ability than Lymph Node Burdenfor Patients with Breast Cancer

Patritumab deruxtecan in HR+HER2−advanced breast cancer: a phase 2 trial

Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery